MetaCap

Redhill Biopharma Insider Trades

NASDAQ: RDHLHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.281-0.0423 (-13.08%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
3 · $4.42K
Shares bought / sold
0 / 44.18M
Net activity
Net selling $4,418

Redhill Biopharma insider activity

Over the last 12 months, Redhill Biopharma insiders reported 3 transactions on SEC Form 4: 0 open-market purchases and 3 sales. Insiders bought $0 and sold $4,418 worth of stock, for net insider selling of $4,418. The largest seller was Raday Gilead, with $4,418 in reported sales.

The most recent filing shows Raday Gilead (Chief Operating Officer) selling 14,310,000 shares at $0.0001 on Oct 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RDHL's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

RDHL insider transactions

Redhill Biopharma insider transactions
DateInsiderTypeSharesValueFiling
Oct 1, 2026Raday GileadChief Operating OfficerSale14,310,000$1.43KForm 4
Jul 10, 2026Raday GileadChief Operating OfficerSale14,130,000$1.41KForm 4
Apr 6, 2026Raday GileadChief Operating OfficerSale15,740,000$1.57KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related